Radiopharm Theranostics

Contributing Author

Recent Articles by Radiopharm Theranostics

Jun-24	Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia RADX GlobeNewswire
Jun-11	Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases RADX GlobeNewswire
Jun-04	Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors RADX GlobeNewswire
Jun-02	Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake RADX GlobeNewswire
May-19	ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 RADX GlobeNewswire
May-12	Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC) RADX GlobeNewswire
May-07	Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference RADX GlobeNewswire